WallStSmart

Kenvue Inc. (KVUE)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 5064% more annual revenue ($15.29B vs $296.12M). KVUE leads profitability with a 10.6% profit margin vs -2.0%. SKIN appears more attractively valued with a PEG of 0.93. KVUE earns a higher WallStSmart Score of 66/100 (B-).

KVUE

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.0Quality: 4.5
Piotroski: 4/9Altman Z: 1.22

SKIN

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 2.0Value: 6.0Quality: 4.5
Piotroski: 6/9Altman Z: -0.38
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-87.5%)

Margin of Safety

-87.5%

Fair Value

$9.89

Current Price

$19.79

$9.90 premium

UndervaluedFair: $9.89Overvalued

Intrinsic value data unavailable for SKIN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

SKIN2 strengths · Avg: 9.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

PEG RatioValuation
0.938/10

Growing faster than its price suggests

Areas to Watch

KVUE3 concerns · Avg: 3.3/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

SKIN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$109.36M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Revenue GrowthGrowth
-6.7%2/10

Revenue declined 6.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth.

Bull Case : SKIN

The strongest argument for SKIN centers on Price/Book, PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bear Case : KVUE

The primary concerns for KVUE are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 6.65 is elevated, increasing financial risk.

Key Dynamics to Monitor

KVUE profiles as a value stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 1.08 — expect wider price swings.

KVUE is growing revenue faster at 4.5% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (66/100 vs 44/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?